Immunomodulation for Pompe Disease with high sustained antibodies against enzyme replacement therapy

Med Clin (Barc). 2021 Oct 22;157(8):403-405. doi: 10.1016/j.medcli.2020.09.017. Epub 2021 Jan 30.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Enzyme Replacement Therapy
  • Glycogen Storage Disease Type II* / drug therapy
  • Humans
  • Immunomodulation
  • Treatment Outcome